Health CanadaGeneral Alert
Antipsychotic drugs: Labelling update regarding the risk of abnormal muscle move...
Published: June 15, 2011Recall ID: 23032Category: generalCountry: Canada
Reason for Recall / Hazard
New safety information
Product Description & Identification
Antipsychotic drugs: Labelling update regarding the risk of abnormal muscle movements and withdrawal symptoms in newborns exposed during pregnancy
Additional Source Details
| Field | Value |
|---|---|
| N I D | 23032 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/antipsychotic-drugs-labelling-update-regarding-risk-abnormal-muscle-movements-and |
| Issue | New safety information |
| Title | Antipsychotic drugs: Labelling update regarding the risk of abnormal muscle movements and withdrawal symptoms in newborns exposed during pregnancy |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2011-06-15 |
| Organization | Communications and Public Affairs Branch |